WEBINAR
From Patient to Biomarker: Sourcing, Processing and the right sample strategy
October 13th, 2026 | 17:00 CEST / 11:00 ET / 08:00 PT
The success of biomarker discovery depends on specimen quality, molecular integrity, and clinical context. High-quality, well-characterized biospecimens are the foundation for reproducible IHC, genomic, proteomic, and spatial biology analyses.
- Why biospecimen quality matters for biomarker research
- How a strong biospecimen strategy can reduce experimental variability
- Strategies for specimen selection and characterization
- Learn about our industry-leading inventory
Speaker
Katharina Krohn
Senior Director Global Biobanks
Katharina Krohn leads global Surgical and Liquid Biobanking operations at Crown Bioscience. Since joining in 2014, she has continuously expanded the company’s biobanking capabilities, founding the Liquid Biopsy Biobank in 2016 and successfully re-launching the Surgical Biobank in 2018. Today, she manages global sample logistics, clinical data management, and inventory analytics.
